Clearwater Capital Advisors’s Chemours CC Stock Holding History

Clearwater Capital Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-60	Closed	-$3K	–	238
2018 Q1	$3K	Buy	+60	New	+$3K	﹤0.01%	562

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clearwater Capital Advisors's CC Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Chemours (CC) in Q2 2018, closing a stake of 60 shares — an estimated $3K sold.

Clearwater Capital Advisors first reported a position in CC in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

Clearwater Capital Advisors reported no remaining Chemours position as of Q2 2018 after selling out during the quarter.
Clearwater Capital Advisors sold 60 Chemours shares in Q2 2018, an estimated $3K.
Clearwater Capital Advisors first reported a position in Chemours in Q1 2018 and held it in 1 quarter.
Clearwater Capital Advisors's Chemours position peaked at $3K in Q1 2018.
558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.